Low Oxygen Exposure for Obesity
(LOWS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how spending nights in low-oxygen environments might affect weight loss and body composition in adults with obesity. Participants will sleep in special tents that simulate high-altitude conditions to determine the impact on energy balance and metabolism during a calorie-restricted diet. The trial includes two groups: one experiencing low oxygen levels (Normobaric hypoxia, NH) and another with normal oxygen levels (Normobaric normoxia, NN), both using similar tent setups. Individuals living with obesity, fully vaccinated against COVID-19, and willing to sleep in a tent for eight hours nightly might be a good fit. As an unphased trial, this study offers a unique opportunity to explore innovative weight loss methods.
Will I have to stop taking my current medications?
Yes, you will need to stop taking any medications that interfere with oxygen delivery or transport, such as sedatives, sleeping aids, tranquilizers, diuretics, and alpha or beta blockers, for 4 weeks before and throughout the study.
What prior data suggests that this protocol is safe for adults with obesity?
Research has shown that normobaric hypoxia, which involves lower oxygen levels similar to those at high altitudes, is generally safe. Studies have placed participants in these conditions during exercise or rest. The results mostly indicate positive outcomes with no serious side effects. One study found that participants who did light exercise in normobaric hypoxia for 8 weeks lost more weight without major issues.
Another study examined individuals exposed to lower oxygen levels without exercising and found they lost body fat and weight, again without serious problems. This suggests normobaric hypoxia is well-tolerated.
Overall, while more research is beneficial, current evidence suggests this approach is safe.1234Why are researchers excited about this trial?
Researchers are excited about using normobaric hypoxia (NH) for obesity because it offers a non-invasive and novel approach by mimicking high-altitude conditions to potentially aid weight loss. Unlike standard treatments like lifestyle changes, medications, or surgery, NH involves overnight exposure to reduced oxygen levels, which may boost metabolism and promote fat loss. This method leverages a unique mechanism of action by creating a controlled low-oxygen environment, which could be more accessible and less risky than surgical interventions.
What evidence suggests that normobaric hypoxia might be an effective treatment for obesity?
This trial will compare the effects of sleeping in a low-oxygen environment versus a normal oxygen environment on weight loss. Research has shown that sleeping in a low-oxygen environment, like the one in this study, might aid weight loss. Studies have found that low oxygen can reduce appetite. This setting may also improve body composition by lowering body fat and weight. Other research suggests that aerobic exercises in low oxygen result in greater weight and fat loss compared to normal oxygen levels. These effects make low-oxygen environments a promising method for addressing obesity.24567
Who Is on the Research Team?
Claire E. Berryman, PhD, RD
Principal Investigator
Pennington Biomedical Research Center
Are You a Good Fit for This Trial?
This trial is for adults with obesity (BMI between 30-39.9) in Tallahassee, Florida who don't smoke or use certain supplements and medications. They must have completed COVID-19 vaccination, live below ~7,000 feet altitude, and share a home with someone who can respond to safety alarms.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Baseline measurements including body composition, blood volume, and fasting measures are taken
Treatment
Participants undergo 8 weeks of calorie restriction combined with either normobaric hypoxia or normoxia exposure
Follow-up
Participants are monitored for sustained weight loss and metabolic health
What Are the Treatments Tested in This Trial?
Interventions
- Normobaric hypoxia (NH)
- Normobaric normoxia (NN)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Florida State University
Lead Sponsor
Pennington Biomedical Research Center
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator